18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
Trial ID or NCT#
To evaluate 18F-FDOPA PET obtained from PET/CT or PET/MRI imaging in patients with newly diagnosed or recurrent gliomas.
18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
- - Greater than 15 year-old at the time of radiotracer administration - Provides written informed consent - Suspected new diagnosis or suspected recurrence of glioma - Able to remain still for duration of each imaging procedure (about 20 minutes)
- - Less than 15 year-old at the time of radiotracer administra - Unable to provide informed consent - Inability to lie still for the entire imaging time - Inability to complete the needed investigational and standard-of-care imaging examinations due to other reasons (severe claustrophobia, radiation phobia, etc.) - Any additional medical condition, serious intercurrent illness, or other extenuating circumstance that, in the opinion of the Investigator, may significantly interfere with study compliance
Contact us to find out if this trial is right for you.